We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VTYX market cap is 289.74M. The company's latest EPS is USD -3.2566 and P/E is -1.47.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -38.57M | -42.55M | -57.15M | -57.95M | -50.35M |
| Net Income | -35.21M | -38.93M | -53.25M | -54.03M | -46.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.18M | -7.05M | -67.15M | -113.14M | -207.99M |
| Net Income | -4.33M | -28.17M | -85.3M | -108.43M | -192.96M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 371.4M | 389.17M | 348.76M | 321.7M | 277.69M |
| Total Liabilities | 17.51M | 17.55M | 20.96M | 38.06M | 33.77M |
| Total Equity | 353.9M | 371.62M | 327.81M | 283.64M | 243.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 349k | 245k | 291.48M | 371.4M | 277.69M |
| Total Liabilities | 4.48M | 30.9M | 12.28M | 17.51M | 33.77M |
| Total Equity | -4.13M | -30.65M | 279.2M | 353.9M | 243.92M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -98.77M | -30.92M | -80.2M | -114.87M | -166.52M |
| Investing | -74.93M | -18.9M | 15.92M | 54.82M | 100.94M |
| Financing | 167.77M | 48.65M | 51.12M | 52.74M | 53.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.64M | -6.2M | -38.65M | -98.77M | -166.52M |
| Investing | N/A | N/A | -214.37M | -74.93M | 100.94M |
| Financing | 2.95M | 6.13M | 323.55M | 167.77M | 53.33M |
| Market Cap | 289.74M |
| Price to Earnings Ratio | -1.47 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.51 |
| Price to Book Ratio | 1.17 |
| Dividend Yield | - |
| Shares Outstanding | 59.25M |
| Average Volume (1 week) | 697.15k |
| Average Volume (1 Month) | 659.07k |
| 52 Week Change | -85.54% |
| 52 Week High | 40.58 |
| 52 Week Low | 1.865 |
| Spread (Intraday) | 0.25 (5.11%) |
| Company Name | Ventyx Biosciences Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.ventyxbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
